Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 116Carcinoma, Non-Small-Cell Lung 101Carcinoma, Renal Cell 67Colorectal Neoplasms 46Neoplasm Metastasis 40Squamous Cell Carcinoma of Head and Neck 38Carcinoma, Hepatocellular 38Neoplasms 35Lung Neoplasms 34Stomach Neoplasms 33Urinary Bladder Neoplasms 22Hodgkin Disease 20Carcinoma, Transitional Cell 20Brain Neoplasms 20Pancreatic Neoplasms 18Ovarian Neoplasms 18Prostatic Neoplasms 16Head and Neck Neoplasms 16Colonic Neoplasms 16Skin Neoplasms 15Sarcoma 14Glioblastoma 14Adenocarcinoma Of Esophagus 14Triple Negative Breast Neoplasms 13Carcinoma, Merkel Cell 13Small Cell Lung Carcinoma 12Rectal Neoplasms 12Esophageal Neoplasms 12Breast Neoplasms 12Uveal Melanoma 11

Interventions

Bevacizumab 2trifluridine tipiracil drug combination 1gadolinium ethoxybenzyl DTPA 1gadobutrol 1encorafenib 1durvalumab 1Urine Specimen Collection 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Oxaliplatin 1Oviposition 1Nivolumab 1Levoleucovorin 1Leucovorin 1Irinotecan 1Immunotherapy 1IDRX-42 1Hydromorphone 1Fluorouracil 1Fentanyl 1Drug Therapy 1Drainage 1Dietary Supplements 1Colonoscopy 1Cetuximab 1Capecitabine 1Bupivacaine 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Digestive System Diseases × Nivolumab × 1 year × Clear all
NCT02829918 2026-03-11

Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
54 enrolled 11 charts
Gastrointestinal

Biliary Tract Neoplasms, Digestive System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡